Answer first

No cannabis product has FDA approval for fibromyalgia. Trial evidence is mixed and comes from small studies. Nabilone, a synthetic THC capsule, lowered pain and improved sleep in two crossover trials of 40 patients each. Vaporized cannabis at 10 mg THC did not lower spontaneous pain in a 20-patient trial published in Pain in 2019. A 2016 Cochrane review found no reliable evidence that cannabinoids cut fibromyalgia pain. Cannabis remains a Schedule I drug at the federal level, so state programs and federal law do not match.

read more

What fibromyalgia is

The 2016 American College of Rheumatology criteria use two scores. The Widespread Pain Index counts pain across 19 body regions. The Symptom Severity scale scores fatigue, waking unrefreshed, and cognitive problems. Diagnosis needs a WPI of 7 or more with an SSS of 5 or more, or a WPI of 4 to 6 with an SSS of 9 or more. Symptoms must run 3 months or longer. Estimates put prevalence at 2% to 4% of US adults. Women receive the diagnosis about twice as often as men. Onset peaks between ages 30 and 50.

related article

What the trials found

Nabilone

Skrabek and colleagues gave 40 patients nabilone or placebo for 4 weeks. The nabilone group reported less pain and less anxiety. Ware and colleagues ran a crossover trial with 40 patients and found better sleep and lower pain scores. Both trials were small. Both listed side effects: drowsiness, dizziness, and dry mouth.

medical cannabis for fibromyalgia side effects

Vaporized cannabis

van de Donk and colleagues tested pharmaceutical-grade cannabis in 20 patients. THC doses of 10 mg and 20 mg did not lower spontaneous pain scores against placebo. The 20 mg dose did raise the threshold for electrical pain. The study ran in a lab, so the result may not carry over to daily use at home.

related article

Cochrane review

Walitt and colleagues reviewed the literature in 2016. They found no evidence that cannabinoids reduce fibromyalgia pain by 30% or more. They rated the evidence as low quality. That review included the nabilone trials.

Survey data

Surveys of patients who already use cannabis report pain relief, better sleep, and better mood. Survey data cannot separate the drug effect from expectation. Self-report also carries recall bias.

How the endocannabinoid system fits

THC binds CB1 receptors in the brain and spinal cord. CBD acts on several targets, including serotonin 5-HT1A receptors and TRPV1 channels. Fibromyalgia involves central sensitization, a state where the nervous system amplifies pain signals. CB1 activation can dampen signal transmission in pain pathways. The mechanism is plausible. Plausibility is not proof of clinical benefit.

Products and dosing

US medical programs sell flower, tinctures, capsules, and topicals. THC content runs from under 1% to over 30% in flower. Labels list THC and CBD in milligrams per dose.

Ratios affect tolerability. A 1:1 THC to CBD ratio produces less intoxication than THC alone at the same total cannabinoid dose. CBD does not block all THC effects.

Risks and interactions

Avoid driving for at least 4 hours after inhaling THC. Federal rules bar cannabis use for workers in Department of Transportation safety-sensitive jobs.

Legal status in the US

As of 2024, 38 states and the District of Columbia run medical cannabis programs. Cannabis stays a Schedule I drug under the Controlled Substances Act. The Department of Health and Human Services recommended a move to Schedule III in 2023. The DEA proposed that change in 2024. The rule is not final.

FDA-approved drugs for fibromyalgia

Three drugs carry FDA approval: duloxetine, milnacipran, and pregabalin. Amitriptyline, gabapentin, and cyclobenzaprine are used off label. Ask a doctor about these options before cannabis.

What to ask a doctor